Subcutaneous Neurofibroma Market: How Are MEK Inhibitors and Topical Therapies Redefining Management Beyond Surgical Excision?
Subcutaneous neurofibromas — the benign peripheral nerve sheath tumors arising within the dermis and subcutis, often multiple and disfiguring in neurofibromatosis type 1 (NF1) patients — have historically been managed through surgical debulking with high recurrence rates and functional morbidity, but the Subcutaneous Neurofibroma Market is now reflecting a therapeutic paradigm shift...
0 Commentaires 0 Parts 38 Vue 0 Aperçu
SocioMint https://sociomint.com